From: The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer
RR (Group 1 vs. Group 2)
95% CI
Grade 1–4
V5
0.793
0.659–0.955
V10
0.818
0.697–0.961
V20
0.915
0.813–1.029
V30
0.922
0.864–0.984
Grade 3–4
0.700
0.482–1.017
0.587
0.397–0.869
0.673
0.481–0.943
0.668
0.535–0.834